Casandra
Casandra Test Code QD27814Version 1 (DRAFT)
Performing Lab
COLONSEQ Panel
Clinical Use
Order TestUse
This test is intended to be used as a disease‑specific solid tumor panel to aid the oncologist in prioritizing standard‑of‑care therapy choices for their patients with Colorectal Cancer.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
Mutation (5 genes)
BRAFKRASNRASPIK3CAPTEN
COLONSEQ Panel
SignatureCOLONSEQ Panel
Other • Categorical (e.g., Positive / Negative / Indeterminate)
MSI
SignatureMicrosatellite Instability
Other • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
8-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Sterile biohazard plastic bag OR slide holder for FFPE slides
Collection Instructions
Paraffin‑embedded tissue accompanied by a circled H&E slide indicating the area OR 15 FFPE tissue slides and H&E slide (or 1 additional slide)
Causes for Rejection
Decalcified tissue specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Similar Tests
Other tests from different labs that may be relevant
NeoTYPE® Colorectal Tumor Profile
NeoGenomics
MayoComplete Colorectal Cancer Panel, Next-Generation Sequencing, Tumor
Mayo Clinic Lab
BRAF V600 Mutation Analysis
MPLN
KRAS Mutation Analysis (Extended) in Colorectal Cancer (CRC)
Labcorp
KRAS Gene Mutation Analysis, IVD
Labcorp
Hereditary Colorectal Cancer and Polyposis Panel
Prevention Genetics